CONESTOGA FAMILY OF FUNDS
NSAR-B/A, 1995-12-28
Previous: TEMPLETON GROWTH & TREASURY TRUST SERIES 1, 485BPOS, 1995-12-28
Next: INTERNEURON PHARMACEUTICALS INC, 10-K405, 1995-12-28



<PAGE>      PAGE  1
000 B000000 10/31/95
000 C000000 0000854127
000 D000000 N
000 E000000 F
000 F000000 Y
000 G000000 Y
000 H000000 N
000 I000000 3.0.a
000 J000000 A
001 A000000 CONESTOGA FAMILY OF FUNDS
001 B000000 811-5855
001 C000000 8003442716
002 A000000 680 SWEDESFORD RD.
002 B000000 WAYNE
002 C000000 PA
002 D010000 19087
002 D020000 1658
003  000000 N
004  000000 N
005  000000 N
006  000000 N
007 A000000 Y
007 B000000 11
SIGNATURE   STEVE MEYER                                  
TITLE       CONTROLLER          
 


<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000854127
<NAME> CONESTOGA FAMILY OF FUNDS
<SERIES>
   <NUMBER> 082
   <NAME> SPECIAL EQUITY- RETAIL CLASS
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          OCT-31-1995
<PERIOD-START>                             NOV-01-1994
<PERIOD-END>                               OCT-31-1995
<INVESTMENTS-AT-COST>                            57873
<INVESTMENTS-AT-VALUE>                           58417
<RECEIVABLES>                                      301
<ASSETS-OTHER>                                      80
<OTHER-ITEMS-ASSETS>                                 1
<TOTAL-ASSETS>                                   58799
<PAYABLE-FOR-SECURITIES>                           544
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                          125
<TOTAL-LIABILITIES>                                669
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                         49086
<SHARES-COMMON-STOCK>                             5027
<SHARES-COMMON-PRIOR>                             1099
<ACCUMULATED-NII-CURRENT>                           16
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                           8483
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                           545
<NET-ASSETS>                                     58130
<DIVIDEND-INCOME>                                  351
<INTEREST-INCOME>                                  121
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                   (104)
<NET-INVESTMENT-INCOME>                            368
<REALIZED-GAINS-CURRENT>                          8512
<APPREC-INCREASE-CURRENT>                         1127
<NET-CHANGE-FROM-OPS>                            10007
<EQUALIZATION>                                   38490
<DISTRIBUTIONS-OF-INCOME>                           40
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                            657
<NUMBER-OF-SHARES-REDEEMED>                       (57)
<SHARES-REINVESTED>                                  5
<NET-CHANGE-IN-ASSETS>                           48061
<ACCUMULATED-NII-PRIOR>                              5
<ACCUMULATED-GAINS-PRIOR>                        (583)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                              480
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                    648
<AVERAGE-NET-ASSETS>                               554
<PER-SHARE-NAV-BEGIN>                             9.37
<PER-SHARE-NII>                                    .12
<PER-SHARE-GAIN-APPREC>                           2.12
<PER-SHARE-DIVIDEND>                             (.12)
<PER-SHARE-DISTRIBUTIONS>                        (.07)
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              11.42
<EXPENSE-RATIO>                                    .27
<AVG-DEBT-OUTSTANDING>                               0
<AVG-DEBT-PER-SHARE>                                 0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission